Global Alliance for Tb Drug Development Non Profit Organisation

Global Alliance for Tb Drug Development Non Profit Organisation is a research organisation in New York, United States that has taken part in 8 EU-funded projects since 2011, receiving €1.9M in EU funding.

EU funding received€1.9M
EU projects8
As coordinator0
Running now6
First EU project2011
Latest project2026
CountryUnited States
EU registration (PIC)988947981
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Global Alliance for Tb Drug Development Non Profit Organisation's own share of each project, not the project's full budget.

  • Horizon 2020€1.4M · 3 projects
  • Horizon Europe€408k · 4 projects
  • FP7 (2007 to 2013)€128k · 1 project

Projects

8 EU-funded projects, newest first. Each links to the official record.

  • END2AMRPartner

    European Novel Drug research to Address Microbial infections and drug Resistance

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • EX-DR TBAssociated partner

    EX-DR TB: Elimination of Extensive Drug Resistance Through better Regimens for TB

    Horizon Europe · 2025–2031 · Project on CORDIS ↗

  • TEBULAAssociated partner

    Telacebec to Control Buruli Ulcer and Leprosy in Africa (TEBULA)

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • ITHEMYCPartner

    Novel immunotherapies for tuberculosis and other mycobacterial diseases

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €408ktheir share
  • UNITE4TBPartner

    ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS

    Horizon 2020 · 2021–2028 · Project on CORDIS ↗

    €1.4Mtheir share
  • ERA4TBPartner

    EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  • EU-PEARLPartner

    EU Patient- cEntric clinicAl tRial pLatform

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

  • ORCHIDPartner

    Open Collaborative Model for Tuberculosis Lead Optimisation

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €128ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antibiotic resistance
  • artificial intelligence
  • bacteriology
  • diabetes
  • drug discovery
  • drug resistance
  • evolutionary biology
  • governance
  • immunotherapy
  • microbiology
  • pandemics
  • primatology
  • simulation software
  • social inequalities

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime